Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors of paraneoplastic pemphigus.
Leger S, Picard D, Ingen-Housz-Oro S, Arnault JP, Aubin F, Carsuzaa F, Chaumentin G, Chevrant-Breton J, Chosidow O, Crickx B, D'incan M, Dandurand M, Debarbieux S, Delaporte E, Dereure O, Doutre MS, Guillet G, Jullien D, Kupfer I, Lacour JP, Leonard F, Lok C, Machet L, Martin L, Paul C, Pignon JM, Robert C, Thomas L, Weiller PJ, Ferranti V, Gilbert D, Courville P, Houivet E, Benichou J, Joly P. Leger S, et al. Among authors: thomas l. Arch Dermatol. 2012 Oct;148(10):1165-72. doi: 10.1001/archdermatol.2012.1830. Arch Dermatol. 2012. PMID: 22801794
PPAD: a tool for presumption of atopic dermatitis.
Misery L, Ortonne JP, Cambazard F, Guillet G, Thomas L, Lorette G, Durosier V, Rahhali N, Auges M, Taieb C. Misery L, et al. Among authors: thomas l. J Dermatol. 2012 Feb;39(2):151-5. doi: 10.1111/j.1346-8138.2011.01381.x. Epub 2011 Nov 2. J Dermatol. 2012. PMID: 22044192
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
Maubec E, Chaudru V, Mohamdi H, Blondel C, Margaritte-Jeannin P, Forget S, Corda E, Boitier F, Dalle S, Vabres P, Perrot JL, Lyonnet DS, Zattara H, Mansard S, Grange F, Leccia MT, Vincent-Fetita L, Martin L, Crickx B, Joly P, Thomas L; French Familial Melanoma Study Group; Bressac-de Paillerets B, Avril MF, Demenais F. Maubec E, et al. Among authors: thomas l. J Am Acad Dermatol. 2012 Dec;67(6):1257-64. doi: 10.1016/j.jaad.2012.05.014. Epub 2012 Jul 26. J Am Acad Dermatol. 2012. PMID: 22841127
Dermoscopic examination of nail pigmentation.
Ronger S, Touzet S, Ligeron C, Balme B, Viallard AM, Barrut D, Colin C, Thomas L. Ronger S, et al. Among authors: thomas l. Arch Dermatol. 2002 Oct;138(10):1327-33. doi: 10.1001/archderm.138.10.1327. Arch Dermatol. 2002. PMID: 12374538
Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study.
Zalaudek I, Kittler H, Marghoob AA, Balato A, Blum A, Dalle S, Ferrara G, Fink-Puches R, Giorgio CM, Hofmann-Wellenhof R, Malvehy J, Moscarella E, Puig S, Scalvenzi M, Thomas L, Argenziano G. Zalaudek I, et al. Among authors: thomas l. Arch Dermatol. 2008 Apr;144(4):509-13. doi: 10.1001/archderm.144.4.509. Arch Dermatol. 2008. PMID: 18427045 Clinical Trial.
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Robert C, Thomas L, Bondarenko I, O'Day S, Weber J, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH Jr, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD. Robert C, et al. Among authors: thomas l. N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639810 Free article. Clinical Trial.
5,369 results